When a snakebite occurs, time is tissue. Healthcare professionals treating envenomation must be confident in the treatment they choose. To ensure CroFab meets the highest level of quality and supply consistency, our manufacturing process takes us around the globe. Join us in this immersive experience to see why CroFab is the choice for comprehensive coverage of all North American pit viper envenomations.
 

Our CroFab journey begins in the United States with the extraction of venom. The venom of 4 different geographically and clinically relevant North American pit viper species native to the US is separately collected.¹
The standards, expertise, and animal care we provide make a critical difference in the quality of venoms produced.

 

Visit our site in South Australia, where 4 separate flocks of Australian sheep will be immunized with the 4 separate batches of native US pit viper venoms.² Australia is a country that has negligible presence of prion disease, ensuring a clean host animal for CroFab manufacturing.³ Our Australian sites are highly regulated and inspected to further ensure high‐quality serum.⁴

 

Visit our site in Wales, which was intentionally designed for bioprocessing serum, isolating the immunoglobulin, or IgG, and purifying the venom‐specific protein (Fab) fragments to create CroFab. Our comprehensive process allows you to control with confidence and choose CroFab to effectively treat your patients when time is tissue.²